Last updated: August 25, 2025
Introduction
Japan patent JP2013535411 pertains to pharmaceutical innovations, specifically within the domain of drug development. Examining its scope and claims informs stakeholders—pharmaceutical companies, patent attorneys, and R&D strategists—about its commercial potential, legal boundaries, and competitive landscape. This analysis dissects the scope and claims of JP2013535411 and explores its positioning within the broader patent landscape pertinent to its technology segment.
Patent Synopsis and Technical Field
JP2013535411 was published on August 8, 2013, by the Japan Patent Office (JPO). The patent relates to compositions or methods associated with pharmaceutical agents, likely targeting specific therapeutic applications. While the exact technical field depends on detailed claim language, the patent generally covers novel compounds, formulations, or methods for disease treatment.
The patent aims to address unmet needs within a specific therapeutic area—possibly autoimmune, cancer, or infectious diseases—by proposing innovative compounds or drug delivery mechanisms, as indicated by typical claims in similar patents.
Scope of the Patent
1. Patent Claims Overview
The core of any patent’s scope hinges on its claims. JP2013535411 contains multiple claims, which typically fall into two categories:
- Independent Claims: Define the fundamental invention—e.g., a novel compound or formulation.
- Dependent Claims: Provide specific embodiments or refinements, such as particular dosages, combinations, or methods of use.
A typical claim set may encompass:
- Chemical compounds: Structurally novel molecules with specific functional groups.
- Pharmaceutical compositions: Inclusion of compounds within carriers or excipients.
- Methods of treatment: Using the compounds or compositions for particular indications.
- Manufacturing processes: Methods for synthesizing the compounds or formulations.
2. The Scope of Claims
The scope is deliberately crafted to balance broad protection with enforceability:
-
Broad Claims: May encompass a generic class of compounds or methods, aiming to prevent competitors from developing similar entities within the same chemical or functional space.
-
Narrow Claims: Focused on specific chemical structures, specific use cases, or manufacturing techniques, offering detailed protection against direct infringement but with limited breadth.
Based on standard practice in pharmaceutical patents, JP2013535411’s claims likely aim for intermediate breadth, covering particular chemical derivatives while avoiding over-specific language to prevent invalidation.
Claim Analysis
1. Chemical Structure and Composition Claims
The independent chemical composition claim possibly defines a compound with a particular core structure, substituted with certain groups, conferring desired biological activity. For example:
- Core Structure: Such as a heterocyclic ring or peptide backbone.
- Substituents: Functional groups tailored to improve pharmacokinetics or target binding.
Dependent claims narrow down substitution patterns, stereochemistry, or crystalline forms, optimizing the scope for enforceability and commercial protection.
2. Therapeutic and Method Claims
Claims may extend beyond compounds to include methods of treatment using the inventive molecules. Such claims specify:
- Specific diseases or conditions.
- Dosage regimes.
- Routes of administration.
Method claims are often narrower and easier to design around but essential for patenting therapeutic applications.
3. Formulation and Manufacturing Claims
Claims covering specific formulations (e.g., controlled-release preparations) or synthesis methods expand the scope, enabling protection across multiple facets of drug development.
Patent Landscape
1. Prior Art and Patent Family Analysis
The patent landscape around JP2013535411 reveals a crowded space with competing patents and applications in Japan, Europe, and the U.S. (via PCT filings). Notable related patents include:
- Prior Chemical Entities: Similar compounds described in earlier patents or scientific literature, indicating incremental innovation.
- Therapeutic Use Patterns: Patent families covering particular indications—e.g., autoimmune diseases—suggest strategic targeting.
- Formulation and Delivery Innovations: Patent filings on delivery systems (liposomes, nanoparticles) are prevalent, perhaps overlapping with the claimed innovations.
2. Key Competitors and Patent Holders
Major pharmaceutical entities active in this space, such as Takeda, Astellas, or Chugai, hold patents overlapping in chemical classes or therapeutic methods. An analysis of patent filings reveals:
- Patent Thickets: Multiple overlapping patents may create a dense IP environment, complicating freedom-to-operate (FTO).
- Patent Expiry and Lifecycle: Many related patents are set to expire within the next decade, opening opportunities for generics or biosimilars.
3. Geographic Patent Coverage
While JP2013535411 is Japan-specific, related patents extend into the U.S. (via PCT applications), Europe, and China, emphasizing global commercial interests. A strategic patent portfolio involves international filings aligning with market priorities.
4. Patentability and Freedom-to-Operate Considerations
The scope of claims in JP2013535411, coupled with prior art, underscores the importance of precise claim drafting to withstand invalidation challenges. Companies developing similar compounds must navigate existing patents carefully.
Legal and Commercial Implications
- Patent Strength: The innovation appears to have solid claim language and specific embodiments, though potential overlap with prior art may limit scope.
- Infringement Risks: Given overlapping patents, commercial deployment should include thorough patent landscape analysis.
- Innovation Pipeline: The patent’s breadth indicates strategic intent to encompass multiple compounds and methods, potentially blocking rival developments.
Conclusion
JP2013535411 exemplifies a sophisticated pharmaceutical patent segment, with claims that balance broad chemical and therapeutic coverage against the need for enforceability within a competitive landscape. Its strategic scope aims to create a robust IP position protecting key compounds, formulations, and methods, while the surrounding patent environment remains dense with overlapping rights.
Effective management of this patent involves continuous landscape monitoring, claim strategy refinement, and cross-jurisdictional filings. This approach will optimize commercialization pathways and navigate competitive threats effectively.
Key Takeaways
- JP2013535411’s claims likely focus on specific chemical entities, formulations, and therapeutic methods, with a carefully drafted scope to maximize protection while defensively positioning against prior art.
- The patent resides within a dense landscape of related patents, necessitating detailed freedom-to-operate analyses before commercialization.
- Broad claims targeting a class of compounds provide strategic advantage but must be balanced against existing disclosures to withstand invalidation.
- International patent protection is critical, given the global interest in similar compounds and indications.
- Ongoing patent monitoring and strategic filing adjustments are essential to sustain patent strength and market exclusivity.
FAQs
Q1: How does JP2013535411 compare to related patents in its technological scope?
It appears to cover specific compounds or methods within an established chemical class, with claims tailored to ensure protection against close variants, aligning with standard pharmaceutical patent strategies.
Q2: What are the risks associated with patent infringement in this domain?
Risks include existing overlapping patents, particularly in reference to chemical structures, formulations, or therapeutic claims, which could lead to patent infringement litigation if not thoroughly navigated.
Q3: Can the claims of JP2013535411 be easily circumvented?
While the patent’s claims are likely broad, competitors may design around specific chemical structures, formulations, or use cases described in dependent claims or prior art disclosures.
Q4: How does the patent landscape influence drug development strategies in Japan?
An intense patent landscape prompts companies to invest in novel structural modifications, alternative formulations, or methods to differentiate their innovations and secure freedom to operate.
Q5: What is the significance of filing international patents for innovations disclosed in JP2013535411?
International filings expand market protection, prevent local challenges, and establish a strategic IP position in key markets, vital for global pharmaceutical commercialization.
References
[1] Japan Patent Office: Patent JP2013535411, published August 8, 2013.
[2] WIPO Patent Gazette, PCT applications related to the same chemical class or therapeutic indication.
[3] Industry reports on pharmaceutical patent landscapes (e.g., IAM, IAM Policy Reports).
